Ad is loading...
FSPHX vs HGHRX
FSPHX vs HGHRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FSPHX vs. HGHRX commentary
Jan 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a StrongBuy and HGHRX is a Buy.
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.78B vs. HGHRX (924M). FSPHX (0.00) and HGHRX (0.00) have matching dividends . FSPHX was incepted earlier than HGHRX: FSPHX (44 years) vs HGHRX (18 years). FSPHX is a more actively managed with annual turnover of: 40.00 vs. HGHRX (32.00). FSPHX (0) and HGHRX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : -3.06 vs. HGHRX (-4.99). FSPHX return over 5 years is better than : -4.82 vs. HGHRX (-10.13).
| FSPHX | HGHRX | FSPHX / HGHRX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 44 years | 18 years | - |
| Gain YTD | 1.835 | 1.100 | 167% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.78B | 924M | 733% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -3.06 | -4.99 | 61% |
| Returns for 3 years | -1.51 | -4.45 | 34% |
| Returns for 5 years | -4.82 | -10.13 | 48% |
| Returns for 10 years | 24.91 | -5.91 | -422% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers